While EPC1 is implicated in developmental processes such as hematopoiesis and muscle differentiation, it is also associated with cancer progression, suppressing apoptosis and contributing to drug resistance through interactions with TIP60 and EZH2 [53,54]. Here, KAT5 is linked to cancer.